Tumor necrosis factor-α-mediated severity of idiopathic retinal periphlebitis in young adults (Eales' disease): Implication for anti-TNF-α therapy

Journal of Ocular Biology, Diseases, and Informatics

Volumn 3, Issue 1, 2010, Pages 35-38

  Saxena, Sandeep ^a   Pant, Aditya B ^b   Khanna, Vinay K ^b   Singh, Kamlesh ^a   Shukla, Rajendra K ^b   Meyer, Carsten H ^c   Singh, Vijay K ^d  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b Indian Institute of Toxicological Research   (India)

^c UNIVERSITY OF BONN   (Germany)

^d ARMED FORCES RADIOBIOLOGY RESEARCH INSTITUTE   (United States)

Author keywords

Anti TNF therapy; Cytokine; Eales' disease; Idiopathic retinal periphlebitis; Tumor necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EALES DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS;

EID: 78650217489     PISSN: None     EISSN: 19368445     Source Type: Journal    
DOI: 10.1007/s12177-010-9053-3     Document Type: Article

References (23)

1. Gieser SC, Murphy RP. Eales' disease. In: Ryan SJ, editor. Retina Vol II. Medical retina. St. Louis: CV Mosby; 1994.
2. Atmaca LS, Idil A, Gunduz K. Visualization of retinal vasculitis in Eales disease. Ocul Immunol Inflamm. 1993;1:41-8.
3. Bali T, Saxena S, Kumar D, Nath R. Response time and efficacy of oral methotrexate pulsed therapy in idiopathic retinal periph-lebitis. Eur J Ophthalmol. 2005;15:374-8.
4. Saxena S, Rajasingh J, Biswas S, Kumar D, Shinohara T, Singh VK. Cellular response to retinal S-antigen and interphotoreceptor retinoid binding protein fragments in patients with Eales' disease. Pathobiology. 1999;67:37-44.
5. Saxena S, Srivastava P, Kumar D, Khanna VK, Seth PK. Decreased platelet membrane fluidity in retinal periphlebitis in Eales' disease. Ocul Immunol Inflamm. 2006;14:113-16.
6. Saxena S, Kumar D. A new staging system for idiopathic retinal periphlebitis. Eur J Ophthalmol. 2004;14:236-9.
7. Inomata H, Ishibashi T, Murata T, Iwasaki M, Tahara A, Hata K, et al. Intraocular neovascularization. Nippon Ganka Gakkai Zasshi. 1997;101:906-26.
8. Kawashima M, Shoji J, Kamura Y, Sato Y. Role of chemokines in the vitreous of proliferative diabetic retinopathy. Nippon Ganka Gakkai Zasshi. 2005;109:596-602.
9. Rai G, Saxena S, Kumar H, Singh VK. Human retinal S-antigen: T cell epitope mapping in posterior uveitis patients. Exp Mol Pathol. 2001;70:140-5.
10. Tripathi P, Saxena S, Yadav VS, Naik S, Singh VK. Human S-antigen: peptide determinant recognition in uveitis patients. Exp Mol Pathol. 2004;76:122-8.
11. Armstrong D, Ueda T, Ueda T, et al. Lipid hydroperoxide stimulates retinal neovascularization in rabbit retina through expression of tumor necrosis factor-alpha, vascular endothelial growth factor and platelet-derived growth factor. Angiogenesis. 1998;2:93-104.
12. Dinarello CA. Proinflammatory cytokines. Chest. 2000;118:503-8.
13. Saxena S, Pant AB, Khanna VK, Singh K, Kumar D, Singh VK. Interleukin-1 and tumor necrosis factor-alpha: novel targets for immunotherapy in Eales' disease. Ocul Immunol Inflamm. 2009;17:201-6.
14. Kriegler M, Perez C, DeFay K, Albert I, Lu SD. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell. 1988;53:45-53.
15. Tang P, Hung MC, Klostergaard J. Human pro-tumor necrosis factor is a homotrimer. Biochemistry. 1996;35:8216-25.
16. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, et al. A met al.loproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature. 1997;385:729-33.
17. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 2001;104:487-501.
18. Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003;10:45-65.
19. Chen G, Goeddel DV. TNF-R1 signaling: a beautiful pathway. Science. 2002;296:1634-5.
20. Gaur U, Aggarwal BB. Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol. 2003;66:1403-8.
21. Hunter CA, Timans J, Pisacane P, Menon S, Cai G, Walker W, et al. Comparison of the effects of interleukin-1 alpha interleukin-1 beta and interferon-gamma inducing factor on the production of interferon-gamma by natural killer. Eur J Immunol. 1997;27:2787-92.
22. Theodossiadis PG, Markomichelakis NN, Sfikakis PP. Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation. Retina. 2007;27:399-413.
23. Le Thi HD, Cassoux N, Lebrun-Vignes B, Wechsler B, Bodaghi B, Lehoang P, et al. Therapy of chronic non infectious uveitis. Rev Med Intern. 2007;28:232-41.